Ratings by Cantor Fitzgerald (Kristen Kluska)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/12/2021 Celldex Therapeutics CLDX Maintain Overweight
(N/A)
 
 
  Details
6/30/2021 Ocuphire OCUP Maintain Overweight
(N/A)
 
 
  Details
6/23/2021 Evelo Biosciences Inc EVLO New Coverage Overweight
(N/A)
16.08
(7.25)
-54.91% Details
5/26/2021 Chemomab Therapeutics CMMB New Coverage Overweight
(N/A)
16.07
(12.04)
-25.08% Details
5/19/2021 Taysha Gene Therapies TSHA New Coverage Overweight
(N/A)
21.79
(20.04)
-8.03% Details
5/12/2021 Mustang Bio MBIO Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Ocugen, Inc. OCGN Downgrade Neutral
(Overweight)
9.58
(7.53)
-21.4% Details
4/14/2021 Amicus Therapeutics FOLD Upgrade Overweight
(Neutral)
9.29
(10.87)
17.01% Details
3/31/2021 Lineage Cell Therapeutics Inc. LCTX New Coverage Overweight
(N/A)
2.14
(2.57)
20.09% Details
3/19/2021 Marker Therapeutics MRKR New Coverage Overweight
(N/A)
1.88
(1.78)
-5.32% Details
3/15/2021 Ocuphire OCUP Maintain Overweight
(N/A)
 
 
  Details
3/3/2021 Ocugen, Inc. OCGN Maintain Overweight
(N/A)
 
 
  Details
3/3/2021 Heat Biologics HTBX New Coverage Overweight
(N/A)
8.19
(6.12)
-25.27% Details
2/23/2021 Celldex Therapeutics CLDX Maintain Overweight
(N/A)
 
 
  Details
2/18/2021 Rigel Pharmaceuticals RIGL Maintain Overweight
(N/A)
 
 
  Details
2/12/2021 Amicus Therapeutics FOLD Downgrade Neutral
(Overweight)
18.73
(10.87)
-41.96% Details
2/3/2021 Ocugen, Inc. OCGN Maintain Overweight
(N/A)
 
 
  Details
1/22/2021 iBio, Inc. IBIO New Coverage Overweight
(N/A)
1.45
(1.17)
-19.31% Details
12/28/2020 Amicus Therapeutics FOLD New Coverage Overweight
(N/A)
24.23
(18.73)
-22.7% Details
12/21/2020 uniQure BV QURE Maintain Overweight
(N/A)
 
 
  Details
12/1/2020 Evogene Ltd EVGN New Coverage Overweight
(N/A)
2.96
(2.82)
-4.73% Details
11/20/2020 Ocuphire OCUP New Coverage Overweight
(N/A)
5.52
(5.33)
-3.44% Details
11/19/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
11/12/2020 Galmed Pharmaceuticals GLMD Maintain Overweight
(N/A)
 
 
  Details
11/11/2020 Abeona Therapeutics ABEO Upgrade Overweight
(Neutral)
1.07
(1.18)
10.28% Details
11/6/2020 Celldex Therapeutics CLDX Maintain Overweight
(N/A)
 
 
  Details
11/4/2020 uniQure BV QURE New Coverage Overweight
(N/A)
39.29
(33.83)
-13.9% Details
10/9/2020 Ocugen, Inc. OCGN New Coverage Overweight
(N/A)
0.33
(9.58)
2803.03% Details
9/28/2020 Abeona Therapeutics ABEO Maintain Neutral
(N/A)
 
 
  Details
8/6/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
8/5/2020 Taiwan Liposome Company, Ltd TLC Maintain Overweight
(N/A)
 
 
  Details
7/28/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
7/14/2020 BiomX PHGE Maintain Overweight
(Overweight)
 
 
  Details
6/23/2020 Applied Genetic Technologies Corp. AGTC New Coverage Overweight
(N/A)
6.16
(3.23)
-47.56% Details
6/12/2020 Celldex Therapeutics CLDX Maintain Overweight
(N/A)
 
 
  Details
5/12/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
5/11/2020 HTG Molecular Diagnostics HTGM New Coverage Overweight
(N/A)
0.40
(6.01)
1402.5% Details
4/21/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
4/17/2020 Axovant Gene Therapies AXGT New Coverage Overweight
(N/A)
3.45
(2.10)
-39.13% Details
3/31/2020 BiomX PHGE Maintain Overweight
(N/A)
 
 
  Details
2/27/2020 Mustang Bio MBIO Maintain Overweight
(N/A)
 
 
  Details
2/21/2020 Celldex Therapeutics CLDX New Coverage Overweight
(N/A)
2.23
(55.21)
2375.78% Details
1/30/2020 Galmed Pharmaceuticals GLMD New Coverage Overweight
(N/A)
5.78
(3.05)
-47.23% Details
1/29/2020 Proteostasis Therapeutics PTI Maintain Overweight
(N/A)
 
 
  Details
1/16/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
1/14/2020 PolarityTE PTE Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 BiomX PHGE New Coverage Overweight
(N/A)
9.64
(3.17)
-67.12% Details
12/23/2019 Taiwan Liposome Co. Ltd. TLC New Coverage Overweight
(N/A)
5.70
(7.01)
22.98% Details
12/17/2019 Proteostasis Therapeutics PTI Maintain Overweight
(N/A)
 
 
  Details
12/4/2019 Proteostasis Therapeutics PTI Maintain Overweight
(N/A)
 
 
  Details
11/20/2019 Mustang Bio MBIO New Coverage Overweight
(N/A)
2.57
(2.71)
5.45% Details
11/15/2019 Rigel Pharmaceuticals RIGL New Coverage Overweight
(N/A)
2.29
(3.74)
63.32% Details
11/11/2019 PolarityTE PTE New Coverage Overweight
(N/A)
3.31
(0.71)
-78.55% Details